EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

The Association Between Atrial Fibrillation Burden and Quality of Life

Rajdip Dulai, Neil Sulke, Nick Freemantle, Pier D Lambiase, David Farwell, Neil T Srinivasan, Stuart Tan, Nikhil Patel, Adam Graham, Rick A Veasey

JACC: Clinical Electrophysiology · 2026-01 · 12 (1) · 85-92

DOI: 10.1016/j.jacep.2025.09.013 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2026-01. Verfasst von Rajdip Dulai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Research Department, Eastbourne District General Hospital, East Sussex Hospitals NHS Trust, Eastbourne, United Kingdom; Institute of Cardi…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Quality of Life, Pulmonary Veins, Catheter Ablation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The SHAM-PVI (A Randomized Sham-Controlled Study of Pulmonary Vein Isolation in Symptomatic Atrial Fibrillation) trial demonstrated that pulmonary vein isolation (PVI) reduces atrial fibrillation (AF) burden and enhances quality of life (QoL). However, the relationship between QoL improvements and actual reductions in AF burden remains insufficiently studied, particularly with regard to the potential influence of the placebo effect. OBJECTIVES: This study sought to investigate the relationship between AF burden and patient-reported QoL outcomes in the context of a sham-controlled, double-blind trial comparing PVI to a sham procedure. METHODS: This is a secondary analysis of the SHAM-PVI trial involving 126 patients with symptomatic paroxysmal or persistent AF. Participants were randomized to cryoballoon PVI or a sham procedure, with AF burden measured continuously via an implantable loop recorder. QoL was assessed using the Atrial Fibrillation Effect on Quality-of-Life (AFEQT), Mayo AF-Specific Symptom Inventory (MAFSI), and 36-Item Short Form Health Survey (SF-36) instruments. Associations between AF burden and QoL were analyzed using regression models, including interaction terms for treatment group. RESULTS: Reduction in geometric mean AF burden was statistically significantly associated with improvements in overall AFEQT score (estimate 0.971; 95% CI: 0.962 to 0.981; P < 0.0001), MAFSI symptom severity and frequency, and multiple SF-36 subdomains. The relationship between the geometric mean AF burden and QoL outcomes was constant between the 2 groups. Symptom-specific analysis highlighted stronger associations between AF burden and palpitations, dizziness, shortness of breath, tiredness, unable to exercise, and weakness. CONCLUSIONS: In this secondary analysis of the SHAM-PVI trial, there was a statistically significant relationship observed between AF burden reduction and QoL improvements. The study provides robust evidence for the use of AF burden as a marker of success and further reinforces that PVI exhibits no placebo effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationQuality of LifePulmonary VeinsCatheter AblationHumansMaleFemaleMiddle AgedDouble-Blind MethodAgedTreatment OutcomeCryosurgeryCost of Illness

Stichwörter der Autor:innen

ablationatrial fibrillationburdenplacebopulmonary vein isolationsham

Autor:innen und Institutionen

  • Cardiology Research Department, Eastbourne District General Hospital, East Sussex Hospitals NHS Trust, Eastbourne, United Kingdom; Institute of Cardiovascular Science, University College London, London, United Kingdom;…
  • Institute of Cardiovascular Science, University College London, London, United Kingdom.
  • Institute for Clinical Trials and Methodology, University College London, London, United Kingdom.
  • Mid and South Essex NHS Foundation Trust, The Essex Cardiothoracic Centre, Basildon, Essex, United Kingdom.
  • Cardiology Research Department, Eastbourne District General Hospital, East Sussex Hospitals NHS Trust, Eastbourne, United Kingdom.
  • Nottingham University Hospital NHS Trust, Nottingham, United Kingdom.

Zitieren

APA

Dulai, R., Sulke, N., Freemantle, N., Lambiase, P. D., Farwell, D., Srinivasan, N. T., Tan, S., Patel, N., Graham, A., & Veasey, R. A. (2026). The Association Between Atrial Fibrillation Burden and Quality of Life. JACC: Clinical Electrophysiology, 12(1), 85-92. https://doi.org/10.1016/j.jacep.2025.09.013

Vancouver

Dulai R, Sulke N, Freemantle N, Lambiase PD, Farwell D, Srinivasan NT, et al. The Association Between Atrial Fibrillation Burden and Quality of Life. JACC: Clinical Electrophysiology. 2026;12(1):85-92. doi:10.1016/j.jacep.2025.09.013

BibTeX
@article{Dulai2026,
  author = {Dulai, Rajdip and Sulke, Neil and Freemantle, Nick and Lambiase, Pier D and Farwell, David and Srinivasan, Neil T and Tan, Stuart and Patel, Nikhil and Graham, Adam and Veasey, Rick A},
  title = {The Association Between Atrial Fibrillation Burden and Quality of Life},
  journal = {JACC: Clinical Electrophysiology},
  year = {2026},
  volume = {12},
  number = {1},
  pages = {85--92},
  doi = {10.1016/j.jacep.2025.09.013}
}
Kostenlos starten →